For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and the formulated version represents a genuine advancement . These innovative therapies preserve the transthyretin protein, preventing its destructive build-up and lessening the impact of the condition . Patients are no… Read More